medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2018, Número 3

<< Anterior Siguiente >>

Ann Hepatol 2018; 17 (3)


Non-Alcoholic Fatty Liver Disease in Children and Adolescents: Lifestyle Change - a Systematic Review and Meta-Analysis

Utz-Melere M, Targa-Ferreira C, Lessa-Horta B, Epifanio M, Mouzaki M, Mattos AA

Idioma: Ingles.
Referencias bibliográficas: 45
Paginas: 345-354
Archivo PDF: 165.99 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Nobili V, Manco M, Devito R, Ciampalini P, Piemonte F, Marcellini M. Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2006; 24: 1553-61.

  2. Corte CD, Alisi A, Saccari A, De Vito R, Vania A, Nobili V. Nonalcoholic fatty liver in children and adolescents: an overview. J Adolesc Health 2012; 51: 305-12.

  3. Rodríguez G, Gallego S, Breidenassel C, Moreno LA, Gottrand F. Is liver transaminases assessment an appropriate tool for the screening of non-alcoholic fatty liver disease in at risk obese children and adolescents? Nutr Hosp 2010; 25: 712-17.

  4. Hsu E, Murray K. Is nonalcoholic fatty liver disease in children the same disease as in adults? Clin Liver Dis 2012; 16: 587-98.

  5. Instituto Brasileiro de Geografia e Estatística (IBGE). Pesquisa de Orçamentos Familiares 2008-2009: antropometria e estado nutricional de crianças, adolescentes e adultos no Brasil. Rio de Janeiro: IBGE, 2011.

  6. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012; 142: 1592-609.

  7. Ued FV, Weffort VRS. Vitaminas antioxidantes no contexto da doença hepática gordurosa não alcoólica em crianças e adolescentes obesos. Rev Paul Pediatr 2013; 31: 523-30.

  8. Alp H, Karaarslan S, Eklioglu BS, Atabek ME, Altýn H, Baysal T. Association between nonalcoholic fatty liver disease and cardiovascular risk in obese children and adolescents. Can J Cardiol 2013; 29: 1118-25.

  9. Ciba I, Widhalm K. The association between non-alcoholic fatty liver disease and insulin resistance in 20 obese children and adolescents. Acta Paediatr 2007; 96: 109-12.

  10. Miriam MB, Abrams SH, Barlow SE, Caprio S, Daniels SR, Kohli R, Mouzaki M, et al. NASPGHAN Clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children. J Pediatr Gastroenterol Nutr 2016; 64: 319-4.

  11. Moran JR, Ghishan FK, Halter SA, Greene HL. Steatohepatitis in obese children: a cause of chronic liver dysfunction. Am J Gastroenterol 1983; 78: 374-7.

  12. Molleston JP, White F, Teckman J, Fitzgerald JF. Obese children with steatohepatitis can develop cirrhosis in childhood. Am J Gastroenterol 2002; 97: 2460-2.

  13. Welsh JA, Karpen S, Vos MB. Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010. J Pediatr 2013; 162: 496-500.

  14. Nobili V, Manco M, Devito R, Di Ciommo V, Comparcola D, Sartorelli MR, Piemonte F, et al. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology 2008; 48: 119-28.

  15. Feldstein AE, Charatcharoenwitthaya P, Treprasertsuk S, Benson JT, Enders FB, Angulo P. The natural history of nonalcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut 2009; 58: 1538-44.

  16. Grønbæk H, Lange A, Birkebaek NH, Holland-Fischer P, Solvig J, Hørlyck A, Kristensen K, et al. Effect of a 10-week weight loss camp on fatty liver disease and insulin sensitivity in obese Danish children. J Pediatr Gastroenterol Nutr 2012; 54: 223-8.

  17. Musso G, Gambino R, Cassader M, Pagano G. A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease. Hepatology 2010; 52: 79-104.

  18. Bradford V, Dillon JF, Miller MH. Lifestyle interventions for the treatment of non-alcoholic fatty liver disease. Hepat Med 2013; 14: 1-10.

  19. 19- Santomauro M, Valeri MP, Fernández M, Camacho N, Molina Z, Cicchetti R, Valeri L, et al. Non-alcoholic fatty liver disease and its association with clinical and biochemical variables in obese children and adolescents: effect of a one-year intervention on lifestyle. Endocrinol Nutr 2012; 59: 346-53.

  20. Wang CL, Liang L, Fu JF, Zou CC, Hong F, Xue JZ, Lu JR, et al. Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children. World J Gastroenterol 2008; 14: 1598-602.

  21. Keating SE, Hackett DA, George J, Johnson NA. Exercise and non-alcoholic fatty liver disease: A systematic review and meta-analysis. J Hepatol 2012; 57: 157-66.

  22. Koot BGP, Slootweg OHB, Smeulders CLJT, Rijcken THP, Korevaar JC, van Aalderen WM, Jansen PLM, et al. Lifestyle intervention for non-alcoholic fatty liver disease: prospective cohort study of its efficacy and factors related to improvement. Arch Dis Child 2011; 96: 669-74.

  23. Lee S, Bacha F, Hannon T, Kuk JL, Boesch C, Arslanian S. Effects of Aerobic Versus Resistance Exercise Without Caloric Restriction on Abdominal Fat, Intrahepatic Lipid, and Insulin Sensitivity in Obese Adolescent Boys A Randomized, Controlled Trial. Diabetes 2012; 61: 2787-2795.

  24. Schwimmer JB. Clinical advances in pediatric nonalcoholic fatty liver disease. Hepatology 2016; 63: 1718-25.

  25. Nobili V, Alisi A, Newton KP, Schwimmer JB. Comparison of the phenotype and approach to pediatric vs adult patients with nonalcoholic fatty liver disease. Gastroenterology 2016; 150: 1798-810.

  26. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: International survey. BMJ 2000; 320: 1-6.

  27. Van der Heijden GJ, Wang ZJ, Chu ZD, Sauer PJ, Haymond MW, Rodriguez LM, Sunehag AL. A 12-Week Aerobic Exercise Program Reduces Hepatic Fat Accumulation and Insulin Resistance in Obese, Hispanic Adolescents. Obesity 2010; 18: 384-90.

  28. Antunes BDMM, Monteiro PA, Silveira LS, Cayres SU, Silva CBD, Júnior F, Forte I. Effect of concurrent training on risk factors and hepatic steatosis in obese adolescents. Rev Paul Pediatr 2013; 31: 371-6.

  29. Tazawa Y, Noguchi H, Nishinomiya F, Takada G. Effect of weight changes on serum transaminase activities in obese children. Acta Paediatr Jpn 1997; 39: 210-14.

  30. Tock L, Dâmaso AR, De Piano A, Carnier J, Sanches PL, Lederman HM, Ernandes RMY, et al. Long-term effects of metformin and lifestyle modification on nonalcoholic fatty liver disease obese adolescents. J Obes 2010.

  31. Tock L, Prado WL, Caranti DA, Cristofalo DM, Lederman H, Fisberg M, Siqueira KO, et al. Nonalcoholic fatty liver disease decrease in obese adolescents after multidisciplinary therapy. Eur J Gastroen Hepat 2006; 18: 1241-1245.

  32. Nadeau KJ, Ehlers LB, Zeitler PS, Love-Osborne K. Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents. Pediatr Diabetes 2009; 10: 5-13.

  33. Farris JW, Taylor L, Williamson M, Robinson C. A 12-week interdisciplinary intervention program for children who are obese. Cardiopulm Phys Ther J 2011; 22: 12.

  34. Reinehr T, Schmidt C, Toschke AM, Andler W. Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study. Arch Dis Child 2009; 94: 437-42.

  35. Akcam M, Boyaci A, Pirgon O, Kaya S, Uysal S, Dundar BN. Therapeutic effect of metformin and vitamin E versus prescriptive diet in obese adolescents with fatty liver. Int. J Vitam Nutr Res 2011; 81: 398-406.

  36. Vajro P, Franzese A, Valerio G, Iannucci MP, Aragione N. Lack of efficacy of ursodeoxycholic acid for the treatment of liver abnormalities in obese children. J Pediatr 2000; 136: 739-43.

  37. Verduci E, Pozzato C, Banderali G, Radaelli G, Arrizza C, Rovere A, Riva E, et al. Changes of liver fat content and transaminases in obese children after 12-mo nutritional intervention. World J Hepatol 2013; 5: 505-12.

  38. Pozzato C, Verduci E, Scaglioni S, Radaelli G, Salvioni M, Rovere A, Cornalba G, et al. Liver fat change in obese children after a 1-year nutrition-behavior intervention. J Pediatr Gastroenterol Nutr 2010; 51: 331-5.

  39. Nobili V, Marcellini M, Devito R, Ciampalini P, Piemonte F, Comparcola D, Sartorelli MR, et al. NAFLD in children: A prospective clinical-pathological study and effect of lifestyle advice. Hepatology 2006; 44: 458-65.

  40. Brambilla P, Bedogni G, Heo M, Pietrobelli A. Waist circumference- to-height ratio predicts adiposity better than body mass index in children and adolescents. Int J Obes 2013; 37: 943-6.

  41. Javed A, Jumean M, Murad MH, Okorodudu D, Kumar S, Somers VK, Sochor O, et al. Diagnostic performance of body mass index to identify obesity as defined by body adiposity in children and adolescents: a systematic review and metaanalysis. Pediatr Obes 2015; 10: 234-44.

  42. Schwimmer JB, Newton KP, Awai HI, Choi LJ, Garcia MA, Ellis LL, Vanderwall K, at al. Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2013; 38: 1267-77.

  43. Awai HI, Newton KP, Sirlin CB, Behling C, Schwimmer JB. Evidence and recommendations for imaging liver fat in children, based on systematic review. Clin Gastroenterol Hepatol 2014; 12: 765-73.

  44. Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, Mills PR, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 2015; 149: 389-97.

  45. Togashi K, Masuda H, Iguchi K. Effect of diet and exercise treatment for obese Japanese children on abdominal fat distribution. Res Sports Med 2010; 18: 62-70.




2020     |     www.medigraphic.com